Back to Agenda
WHO Town Hall: Safeguarding Public Health - WHO's Vision for Global Regulatory Excellence
Session Chair(s)
Samvel Azatyan, MD, PhD
Team Lead, Regulatory Convergence and Networks (RCN/REG)
World Health Organization (WHO), Switzerland
This session aims to delve into WHO's pivotal role in the evolving landscape of global regulatory excellence. The discussion will revolve around the transformative impact of WHO-listed Authorities on medical product regulation, emphasizing regulatory reliance as a holistic approach to enhance efficiency and accessibility. Additionally, the session will address the pressing issue of substandard/falsified medical products and their potential threats to global health.
Learning Objective : Describe the significance of WHO-listed Authorities in shaping the future of medical product regulation; Examine the concept of regulatory reliance as a key strategy to enhance access and efficiency in global regulatory practices; Discuss the critical role of regulatory excellence in safeguarding public health against the threats posed by substandard/falsified medical products.
Speaker(s)
Elevating Regulatory Reliance: The Strategic Impact of WHO-Listed Authorities in Transforming Global Regulatory Landscapes
Hiiti Sillo, MSc, RPh
World Health Organization (WHO), Switzerland
Unit Head, Regulation and Safety, Department of Regulation and Prequalification
Securing Supply Chains: A Global Imperative
Rutendo Kuwana, RPh
World Health Organization (WHO), Switzerland
Team Lead, Incidents and Substandard/Falsified Medical Products
EMA Update
Emer Cooke, MBA, MSc
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Industry Update
Janis Bernat, MSc
IFPMA, Switzerland
Director, Scientific and Regulatory Affairs
Moderator for Panel Discussion and Q&A
Marion Laumonier, MSc
World Health Organization (WHO), Switzerland
Technical Officer, Regulatory Convergence and Networks
Have an account?